"Intravitreal Injections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.
| Descriptor ID |
D058449
|
| MeSH Number(s) |
E02.319.267.530.475.500
|
| Concept/Terms |
Intravitreal Injections- Intravitreal Injections
- Injection, Intravitreal
- Injections, Intravitreal
- Intravitreal Injection
|
Below are MeSH descriptors whose meaning is more general than "Intravitreal Injections".
Below are MeSH descriptors whose meaning is more specific than "Intravitreal Injections".
This graph shows the total number of publications written about "Intravitreal Injections" by people in this website by year, and whether "Intravitreal Injections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 11 | 11 |
| 2012 | 0 | 16 | 16 |
| 2013 | 3 | 11 | 14 |
| 2014 | 2 | 16 | 18 |
| 2015 | 2 | 33 | 35 |
| 2016 | 2 | 16 | 18 |
| 2017 | 3 | 9 | 12 |
| 2018 | 1 | 19 | 20 |
| 2019 | 1 | 31 | 32 |
| 2020 | 3 | 30 | 33 |
| 2021 | 0 | 23 | 23 |
| 2022 | 0 | 13 | 13 |
| 2023 | 1 | 4 | 5 |
| 2024 | 6 | 4 | 10 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Intravitreal Injections" by people in Profiles.
-
Kalavar M, Sridhar J. Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema. Curr Opin Ophthalmol. 2025 May 01; 36(3):189-198.
-
Durrani AF, Chaudhary V, Garg SJ. Reducing rates of endophthalmitis from intravitreal injections - strategies and areas of controversy. Curr Opin Ophthalmol. 2025 May 01; 36(3):229-236.
-
Zhao CS, Chwialkowski K, Wai KM, Mruthyunjaya P, Rahimy E, Koo EB. Risk of Cataract Surgery Complications in Patients With Prior Intravitreal Injection Therapy. Am J Ophthalmol. 2025 Apr; 272:106-116.
-
Alsoudi AF, Wai KM, Koo E, Parikh R, Mruthyunjaya P, Rahimy E. Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy. JAMA Ophthalmol. 2024 Oct 01; 142(10):972-975.
-
Alsoudi AF, Koo E, Wai K, Mruthyunjaya P, Rahimy E. Ocular Neovascular Conversion and Systemic Bleeding Complications in Patients with Age-Related Macular Degeneration on Anticoagulants. Ophthalmology. 2025 Feb; 132(2):219-227.
-
Rahimy E, Koo EB, Wai KM, Ludwig CA, Kossler AL, Mruthyunjaya P. Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications. Am J Ophthalmol. 2025 Feb; 270:93-102.
-
Shah S, Chou B, Patel M, Watane A, Shah L, Yannuzzi N, Sridhar J. Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S. Curr Opin Ophthalmol. 2024 Sep 01; 35(5):369-375.
-
Alsoudi AF, Wai KM, Koo E, Parikh R, Mruthyunjaya P, Rahimy E. Progression to Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy. JAMA Ophthalmol. 2024 Jul 01; 142(7):662-668.
-
Cullhed Farrell A, Epstein D. RETINAL VEIN OCCLUSIONS BEFORE AND DURING THE COVID-19 PANDEMIC: Visual Outcomes and Treatment Patterns in a Country with no Mandatory Lockdown. Retina. 2024 Jun 01; 44(6):1045-1051.
-
Moshfeghi AA, Khurana RN, Moini H, Sherman S, Reed K, Boucher N, Rahimy E. Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice. BMC Ophthalmol. 2024 May 31; 24(1):229.